483
Immunologix LaboratoriesFDA 483 - Immunologix Laboratories - September 12, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Immunologix Laboratories in Tampa, FL, a nonclinical laboratory, identified one observation. The primary concern was the failure of the study director to ensure proper archiving of raw data and documentation for bioanalytical studies. This indicates a significant issue with data integrity and record-keeping practices.
Open in Dashboard
ID · de680405-0e1a-424b-a14f-fae2baa266cc